Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT study

Research output: Contribution to journalArticleAcademicpeer-review

30 Citations (Scopus)
5 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)124-132
Number of pages9
JournalInternational Journal of Cardiology
Volume235
DOIs
Publication statusPublished - 2017

Cite this